1. Japan Stocks

  2. •

    Commercial services

  3. •

    Miscellaneous commercial services
Soiken Holdings Inc.

Soiken Holdings Inc.

TTSE:2385
217.00
JPY
-3.00
(-1.36%)
6.15BMarket Cap
Nov 12Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
75.3
89.57
97.44
122.83
158.57
208.54
289.32
356.01
341.86
357.36
308.89
197.2
185.35
- -
Basic EPS, GAAP
2.66
0.99
-0.21
1.79
7.13
7.57
21.16
27.97
21.49
30.95
17.27
-25.32
-8.05
- -
Free Cash Flow per Basic Share
3.04
-2.76
-3.67
6.31
3.89
-4.22
16.22
31.35
-5.03
79.95
-5.39
-34.23
19.9
- -
Dividend per Share
- -
- -
- -
- -
- -
0.97
1.99
3.92
5.02
4.97
4.98
5.03
0.01
- -
Book Value per Share
153.51
155.74
157.81
161.76
166.98
171.84
190.87
214.39
230.88
254.14
266.41
238.28
230.22
231.63
Tangible Book Value per Share
152.51
155.1
156.86
160.79
164.88
169.23
188.92
212.92
229.77
252.25
264.63
237.28
229.5
231.04
Basic Weighted Avg Shares
26
26
26
26
26
26
26
26
26
26
26
26
26
26
Sales/Revenue/Turnover
1,966
2,343
2,549
3,213
4,148
5,455
7,568
9,312
8,942
9,348
8,080
5,158
4,849
- -
Operating Margin (%)
2.92
1.19
-0.38
5.68
6.38
5.97
11.45
11.25
10.25
12.93
8.98
-11.83
-2.84
- -
Depreciation Expense
18
18
16
16
21
32
34
35
31
24
25
27
18
- -
Net Income, GAAP
70
26
-6
47
187
198
553
732
562
810
452
-662
-211
- -
Effective Tax Rate (%)
31.31
44.89
203.34
55.95
31.34
38.04
34.53
31.58
36.07
34.76
37.18
- -
- -
- -
Profit Margin (%)
3.54
1.11
-0.22
1.45
4.5
3.63
7.31
7.86
6.29
8.66
5.59
-12.84
-4.35
- -
Working Capital
2,994
3,018
3,472
3,643
3,912
3,834
4,309
5,426
6,000
6,572
6,920
6,085
5,841
5,833
LT Debt
- -
- -
- -
- -
18
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
4,024
4,076
4,128
4,315
4,654
4,635
5,152
5,782
6,232
6,847
7,172
6,249
6,038
6,060
Return on Invested Capital (%)
0.99
0.38
0.24
1.88
3.93
4.23
11.33
12.55
9.42
11.73
6.35
- -
- -
- -
Return on Capital (%)
1.91
0.78
-0.11
0.42
4.14
4.07
10.92
13.12
9.05
12.27
6.39
- -
- -
- -
Return on Common Equity (%)
1.76
0.64
-0.13
1.12
4.34
4.47
11.67
13.8
9.65
12.76
6.64
-10.03
-3.44
- -

Capital Structure

JPY

•

in mil. unless spec.
Jun'24
Dec'25
Dec'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
26
26
26
Market Capitalization
4,368
3,113
6,147

Working Capital

JPY

•

in mil. unless spec.
Jun'24
Dec'25
Dec'26
Total Current Assets
6,765
6,396
6,441
Cash, Cash Equivalents & STI
4,790
4,863
5,324
Accounts Receivable, Net
429
480
284
Inventories
1,121
938
741
Total Current Liabilities
680
538
608
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.15%
1.23%
-3.38%
Free Cash Flow
-244.42%
-306.97%
-158.13%
Net Income, GAAP
-76.71%
-67.61%
-68.18%
Sales/Revenue/Turnover
9.33%
-11.03%
-6.01%
Total Cash Common Dividend
- -
-14.36%
-99.84%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,125
1,716
1,001
1,317
5,158
2025
- -
- -
- -
- -
4,849
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-20.15
1.5
-3.31
-3.35
-25.32
2025
- -
- -
- -
- -
-8.05
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
5.03
2025
- -
- -
- -
- -
0.01
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kentaro Ishigami
Full Time Employees
45
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
Senri Life Science Center Osaka OS Japan 560-0082
IPO Date
Dec 18, 2003
Website
soiken.com
Similar Companies
PayPal Holdings, Inc. (NASDAQ:PYPL)
Shopify Inc. (NASDAQ:SHOP)
Greenland Mines Ltd (NASDAQ:GRML)
Block, Inc. (NYSE:XYZ)
Netcapital Inc. (NASDAQ:NCPL)
Shopify, Inc. Class A (TSX:SHOP)
Business
Soiken Holdings Inc. Soiken Holdings Inc. (2385.T) is a Japan-based holding company primarily engaged in biomarker development and related bioventure activities originating from Osaka University. Founded in July 1994 and headquartered at 13F Senri Life Science Center in Toyonaka, Osaka, the company operates through six main business segments via its subsidiaries: biological evaluation systems including clinical evaluation tests for foodstuffs and biomarker licensing through Soiken Inc.; healthcare support services such as specific health guidance, health checkups, and diabetes prevention for health insurance societies; cosmetics manufacturing and sales focused on placenta extract products under the Placenta Laboratory brand through Bb Laboratories Inc.; dietary supplements featuring imidapeptides from anti-fatigue research projects through Japan Preventive Medicine Inc.; marketing research and post-marketing surveys for health supplements through Evidence Labo Inc.; and functional material development centered on lactoferrin and pharmaceutical compounds like ascochlorin derivatives through NRL Pharma Inc. The company primarily serves pharmaceutical, food, and healthcare sectors in Japan, with additional cosmetics outreach to the Chinese market via a capital alliance with Beautyplus Holdings Hong Kong Limited established in May 2015; its most recent notable ownership development occurred in 2021 when Hangzhou Golong Holding Co., Ltd. acquired a 10.7% stake for 1.1 billion yen, while it maintains ongoing biomarker commercialization efforts including gene therapy vectors through Virus Ikagaku Kenkyusho Inc.